Therapiva is a leading generics pharmaceutical company backed by a strong and innovative R&D facility and a world-class API manufacturing facility. It has a robust product portfolio spread across various therapeutic areas, capable of handling new, complex and hazardous reactions. Therapiva supplies NCEs, cGMP intermediates and KSMs to global innovators. It is equipped with flexible, versatile and advanced infrastructure, tailored to fit any complex chemistry molecules churning out of Innovator’s development pipelines.

The manufacturing facilities complies with all regulatory guidelines and requirements of current Good Manufacturing Practices (cGMP) and are successfully inspected/approved by health and regulatory agencies.